Workflow
Exelixis (EXEL) Beats Q3 Earnings and Revenue Estimates

Exelixis (EXEL) came out with quarterly earnings of 0.78pershare,beatingtheZacksConsensusEstimateof0.78 per share, beating the Zacks Consensus Estimate of 0.68 per share. This compares to earnings of 0.47pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof+14.710.47 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.71%. A quarter ago, it was expected that this drug developer would post earnings of 0.65 per share when it actually produced earnings of $0.75, delivering a surprise of +15.38%.Over the last four quarters, the compan ...